A health economics researcher explains why purchase price is the smallest number in a clinical trial technology decision and what gets left off the budget.
- Research Design Mistakes Even Experienced Analysts Still Make
- The Infrastructure Behind Virtua Health's Push Toward 1.5 Million Studies A Year
- A Framework For Deploying AI In Clinical Trials Without The Hype
- Why Younger Clinical Researchers Are More Wary Of AI Than Their Elders
- Your EDC Query Count Is Trying To Tell You Something
- Inside The Rush To Accelerated Approval: A Consultant's View
- Why Virtua Health's AI Committee Gives IT The Review, Not The Vote
- Building Effective, Retrospective Decision-Grade Disease Registries
ON-DEMAND WEBINARS
Watch to learn how you can build a better data management and compliance monitoring plan for your COAs in your next DCT trial.
Research shows that the global DCT market will reach $14B by 2026. Research also suggests that up to 90% of clinical trials are at risk of failure. Faulty trial designs, patient retention, costs and flawed data collection are drivers for the failure rate in clinical trials. The risks of study failure are reduced by taking a patient- first enterprise platform approach.
Discover the scientific, regulatory, and operational hurdles slowing digital health in clinical trials — and how design, guidance, and validation improvements are moving adoption ahead.
During this virtual presentation from the 2020 Digital Biomarkers & Digital Measurements Summit, industry thought leaders from ActiGraph, Atlantic Council, Elektra Labs, and NeuroLogica answer key questions around the evaluation and evidence required to select digital clinical measures.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1531115888 wearables]( "Wearable DHT 101: Foundations For Use In Regulated Clinical Trials")
Wearable DHT 101: Foundations For Use In Regulated Clinical TrialsDelve into the benefits of continuous sensor data, the scope of wearable use in clinical trials, and the specific sensors and measures employed by wearable DHTs.
-
![GettyImages-1132128949 etmf]( "How Real-Time eTMFs Are Helping Keep Trials On Track")
How Real-Time eTMFs Are Helping Keep Trials On TrackLearn how real-time dashboards assist with the sorting of information so clinical trial and medical affairs teams know what needs to be done, when, and by whom.
-
![Problem solving challenge achievement GettyImages-1271935835]( "Helping Biotechs Overcome 4 Key Challenges")
Helping Biotechs Overcome 4 Key ChallengesDelays in site payments, participant reimbursements, and logistical inefficiencies can create roadblocks for patients and sites.
-
![Electronic Investigator Site File: The Solution for Disaggregated Industries]( "How To Reduce Risk And Effort When Migrating A TMF")
How To Reduce Risk And Effort When Migrating A TMFUtilize this summary of key tips, checklists, and lessons learned to mitigate the risks and efforts associated with migrating a trial master file.
-
![Big data-GettyImages-1023943076]( "Modern Post-Market Trials Driven By RWD – Is Your EDC Ready?")
Modern Post-Market Trials Driven By RWD – Is Your EDC Ready?Explore the transformative role of real-world data (RWD) and advanced Electronic Data Capture (EDC) systems in post-market research, marking a departure from traditional Phase IV trials.
-
![GettyImages-1744064144-pencil-hand-automation-gears-ai]( "The AI Revolution In Clinical Trials")
The AI Revolution In Clinical TrialsAI is reshaping clinical trials by accelerating patient recruitment, optimizing protocol design, and improving data quality—driving faster, more efficient, and more inclusive research outcomes.
-
![fact and myth-GettyImages-1537534263]( "The Top 5 Myths About eCOA In 2025")
The Top 5 Myths About eCOA In 2025Projected to grow 16.1% annually through 2030, eCOA solutions are booming. Uncover the top five myths and misconceptions about eCOAs in 2025 so your clinical teams can make evidence-based decisions.
-
![clinical-trials-site-paymentGettyImages-1959739742]( "From Budgets To Payments")
From Budgets To PaymentsGlobal site payments bring lump-sum invoices, multiple languages, and VAT complexity. Discover how streamlined financial workflows reduce risk and delay.
-
![clinical-ecoa-GettyImages-2255935744]( "A Practical Case For eCOA In Phase I Oncology Clinical Trials")
A Practical Case For eCOA In Phase I Oncology Clinical TrialsPhase I oncology teams can capture meaningful patient outcomes data without added complexity, building a foundation that eases later-phase eCOA demands.
-
![clinical-trial-design-GettyImages-2246070389]( "Managing Medical Coding Dictionary Updates In Clinical Trials")
Managing Medical Coding Dictionary Updates In Clinical TrialsDictionary updates can impact data consistency, safety monitoring, and reporting. Learn key considerations for managing coding version changes while maintaining data integrity.
- The Hidden Costs Of Clinical Trial Technology Nobody Budgets For
- What South Africa's Trial Sites Teach Global Clinical Research
- Research Design Mistakes Even Experienced Analysts Still Make
- The Infrastructure Behind Virtua Health's Push Toward 1.5 Million Studies A Year
- A Framework For Deploying AI In Clinical Trials Without The Hype
RECENT NEWSLETTERS
- 10.22.26 -- AI, RWE, And IRT Are Exposing Trial Workforce Gaps
- 10.15.26 -- AI, Site Burden, And Vendor Risks Are Testing Trials
- 10.08.26 -- AI, RTSM, And Trial Systems Are Still Breaking Down
- 10.03.26 -- Best Of September: AI, Wearables, And Trial Workflow Gaps
- 10.01.26 -- AI, Data Integrity, And Wireless Gaps Are Reshaping Trials
